CAROLYN HANSEN: Open Payments
NPI 1801309190 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,330 in 56 payments from 10 companies in 2025. Trend: 2023 $1,778 · 2024 $1,250 · 2025 $1,330
Food & beverage: $1,330
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 39 | $596 |
| Boston Scientific Corporation | 3 | $150 |
| Medtronic, Inc. | 2 | $122 |
| Astellas Pharma US Inc | 1 | $112 |
| ABBVIE INC. | 3 | $84 |
| 180 Medical, Inc. | 1 | $80 |
| COLOPLAST CORP | 2 | $69 |
| MILLICENT US INC | 3 | $62 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $32 |
| Integra LifeSciences Corporation | 1 | $21 |
Products named: GEMTESA, Axonics, INTERSTIM, Veozah, BOTOX, Altis, MYFEMBREE, INTRAROSA.
Industry payments across TX — which companies pay providers there.
